An internal standard for the quantification of norfloxacin
Related Products
Unlabeled Version(s)
25975Norfloxacin
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Norfloxacin-d5

Item No. 28521

Technical Information
Formal Name
1-(ethyl-1,1,2,2,2-d5)-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid
CAS Number
1015856-57-1
Molecular Formula
C16H13D5FN3O3
Formula Weight
Purity
≥99% deuterated forms (d1-d5)
A solid
CHCl3: Slightly soluble: 0.1-1 mg/mlChloroform: slightlyDMSO: Slightly soluble: 0.1-1 mg/mlDMSO: slightly, heated
SMILES
O=C(O)C1=CN(C([2H])([2H])C([2H])([2H])[2H])C2=CC(N3CCNCC3)=C(F)C=C2C1=O
InChi Code
InChI=1S/C16H18FN3O3/c1-2-19-9-11(16(22)23)15(21)10-7-12(17)14(8-13(10)19)20-5-3-18-4-6-20/h7-9,18H,2-6H2,1H3,(H,22,23)/i1D3,2D2
InChi Key
OGJPXUAPXNRGGI-ZBJDZAJPSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Cayman Chemical
    Neutrophil Biology Wall Poster

    Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.

    DOWNLOAD NOW
    Product Description

    Norfloxacin-d5 is intended for use as an internal standard for the quantification of norfloxacin (Item No. 25975) by GC- or LC-MS. Norfloxacin is a fluoroquinolone antibiotic that inhibits the growth of Gram-positive and Gram-negative bacteria (MICs = 4 and 1 μg/ml for S. aureus and P. aeruginosa, respectively).1 It also inhibits the growth S. pseudintermedius, S. aureus, E. coli, Pasturella, and S. canis isolates from dogs (mean MIC50s = 0.25, 1, 0.03, 1, and 1 μg/ml, respectively).2 Topical administration of norfloxacin (0.1% v/v) reduces corneal ulcer size in a rabbit model of P. aeruginosa corneal infection. It also prevents encrusted cystitis in bladder and increases survival in a rat model of Corynebacterium group D2 infection when administered at a dose of 80 mg/kg per day.3 Formulations containing norfloxacin have been used to treat urinary tract and gynecological infections.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Darrell, R.W., Modak, S.M., and Fox, C.L., Jr. Norfloxacin and silver norfloxacin in the treatment of Pseudomonas corneal ulcer in the rabbit. Trans. Am. Opthalmol. Soc. 82, 75-91 (1984).

    2. Awji, E.G., Damte, D., Lee, S.-J., et alThe in vitro activity of 15 antimicrobial agents against bacterial isolates from dogs. J. Vet. Med. Sci. 74(8), 1091-1094 (2012).

    3. Soriano, F., Rodriguez-Tudela, J.L., Castilla, C., et alTreatment of encrusted cystitis caused by Corynebacterium group D2 with norfloxacin, ciprofloxacin, and teicoplanin in an experimental model in rats. Antimicrob. Agents Chemother. 35(12), 2587-2590 (1991).